Advertisement

Picture EBD Group BIO-Europe 2018 Copenhagen Denmark Partnerships 600x60px
Document › Details

Verona Pharma plc. (4/27/17). "Press Release: Verona Pharma Announces Pricing of Global Offering and Approval to List on the NASDAQ Global Market [Not for any jurisdiction where distribution would constitute a violation of relevant laws]". London.

Region Region United States (USA)
Organisations Organisation Verona Pharma plc (AIM: VRP + Nasdaq Global Market : VRNA)
  Group Verona Pharma (Group)
  Organisation 2 Nasdaq Global Market
  Group Nasdaq OMX (Group)
Products Product respiratory drug
  Product 2 investment banking
Index term Index term Verona Pharma–SEVERAL: investment, 201704 US IPO $78m with 5.768m ADSs at $13.5/ADS at Nasdaq Global Market
Person Person Ebsworth, David (Galenica 200910–201508 CEO Vifor Pharma RETIRES 8/14 before OGS CEO + Bayer Head Pharma
     


   
Record changed: 2017-05-01

Advertisement

Picture [iito] – Putting Information into Context 600x102px

More documents for Verona Pharma (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture EBD Group BIO-Europe 2018 Copenhagen Denmark Partnerships 600x60px




» top